Evidence map›Paper›PMID 2545917›Full record

ArticleJournal of virology1989

Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor.

L S Chang, Y Shi, T Shenk

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 1989. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 171 citations in OpenAlex.

  1. Residual DNA impurities in AAV vectors-nature and transcription.Molecular therapy. Methods & clinical development · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Inducible HEK293 AAV packaging cell lines expressing Rep proteins.Molecular therapy. Methods & clinical development · 2023
    Article
  10. A TNature aging · 2023
    Article
  11. Review
  12. Article
  13. Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Review
  14. Article
  15. Review
  16. Cross-Packaging and Capsid Mosaic Formation in Multiplexed AAV Libraries.Molecular therapy. Methods & clinical development · 2020
    Article
  17. Article
  18. Viruses · 2019
    Review
  19. Article
  20. Adeno-associated virus Rep proteins antagonize phosphatase PP1 to counteract KAP1 repression of the latent viral genome.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

L S ChangHoward Hughes Medical Institute, Department of Biology, Princeton University, New Jersey 08544-1014.
Y Shi
T Shenk
Howard Hughes Medical Institute · US

Funding

STRUCTURE &FUNCTION OF DNA TUMOR VIRUS GENOMESR37CA038965 · NCI · PRINCETON UNIVERSITY · PI SHENK, THOMAS E · 1987 to 2002
$1.1M
STRUCTURE AND FUNCTION OF DNA TUMOR VIRUS GENOMESR01CA038965 · NCI · PRINCETON UNIVERSITY · PI SHENK, THOMAS E · 1985 to 1986
–
NCI NIH HHS CA38965
6 · The paper itself

Abstract

Activity of the adeno-associated virus P5 transcriptional control region was found to be induced by adenovirus E1A gene products. A pair of adjacent sequence elements was found to mediate both basal and E1A-induced P5 activity. The first element is a binding site for the major late transcription factor (MLTF), a factor first identified on the basis of its binding to a specific sequence within the adenovirus major late promoter. The second element is a tandemly repeated 10-base-pair sequence whose relationship to previously described binding sites is unclear. Each element individually conferred E1A responsiveness on a heterologous promoter, and deletion analysis demonstrated that each contributed to the level of P5 activity in the presence of E1A products both in transfection- and infection-based assays. Although deletion of the MLTF binding site led to reduced P5 transcriptional activity in the presence of E1A proteins, the deletion generated enhanced P5 basal activity in the absence of the transcriptional activator. The negative effect of the MLTF binding site in the absence of activator and its positive effect in the presence of activator combine to enhance the magnitude of the response by the P5 control region to E1A gene products.

Indexed as

Gene Expression RegulationPromoter Regions, GeneticAdenovirus Early ProteinsBase SequenceBinding SitesDependovirusDNA, ViralHeLa CellsHumansMolecular Sequence DataOncogene Proteins, ViralRNA, ViralSequence Homology, Nucleic AcidTranscription FactorsTranscription, GeneticTransfectionAdenovirus Early ProteinsDNA, ViralOncogene Proteins, ViralRNA, ViralTranscription Factors

Identifiers

PMID2545917
PMCPMC250925
OpenAlexW2118018893

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.